Calyxo Series C · $33M raised · (2022)

Calyxo, Inc. is a medical device company focused on revolutionizing the treatment of kidney stones. Their flagship product, the CVAC System, is an all-in-one aspiration-based system designed for efficient and effective stone removal. The company has achieved a significant milestone with 40,000 patients treated using their innovative technology, indicating growing clinical adoption.